These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1710385)

  • 81. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity.
    Delwaide PJ; Pennisi G
    Neurology; 1994 Nov; 44(11 Suppl 9):S21-7; discussion S27-8. PubMed ID: 7970007
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Treatment of spasticity].
    Autti-Rämö I
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract]   [Full Text] [Related]  

  • 83. Anti-spasticity medications.
    Al-Shahrani AM
    Saudi Med J; 2003 Jan; 24(1):19-22. PubMed ID: 12590267
    [TBL] [Abstract][Full Text] [Related]  

  • 84. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacokinetics and pharmacodynamics of tizanidine.
    Roberts RC; Part NJ; Pokorny R; Muir C; Leslie GC; Emre M
    Neurology; 1994 Nov; 44(11 Suppl 9):S29-31. PubMed ID: 7970008
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Spastic syndrome and main directions of its treatment].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):4-9. PubMed ID: 14763249
    [No Abstract]   [Full Text] [Related]  

  • 88. Managing spasticity with drugs.
    Simon O; Yelnik AP
    Eur J Phys Rehabil Med; 2010 Sep; 46(3):401-10. PubMed ID: 20927006
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Alpha adrenergic and serotonergic agents in the treatment of spastic hypertonia.
    Nance PW
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):889-905. PubMed ID: 11723869
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Spasticity: revisiting the role and the individual value of several pharmacological treatments.
    Lapeyre E; Kuks JB; Meijler WJ
    NeuroRehabilitation; 2010; 27(2):193-200. PubMed ID: 20871149
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The spinal pathophysiology of spasticity--from a basic science point of view.
    Nielsen JB; Crone C; Hultborn H
    Acta Physiol (Oxf); 2007 Feb; 189(2):171-80. PubMed ID: 17250567
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder.
    Arnsten AF; Steere JC; Hunt RD
    Arch Gen Psychiatry; 1996 May; 53(5):448-55. PubMed ID: 8624188
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Medical treatment of spasticity].
    Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Agren H
    Acta Psychiatr Scand Suppl; 1986; 327():91-113. PubMed ID: 3529831
    [No Abstract]   [Full Text] [Related]  

  • 95. The neurobiological implication of clonidine HCl.
    Gold MS; Pottash AC
    Ann N Y Acad Sci; 1981; 362():191-202. PubMed ID: 7020529
    [No Abstract]   [Full Text] [Related]  

  • 96. [The use of sirdalud in painful muscle tonic syndromes].
    Damulin IV
    Ter Arkh; 1997; 69(10):68-72. PubMed ID: 9471796
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Spasticity].
    Zavalishin IA; Barkhatova VP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(3):68-70. PubMed ID: 9157765
    [No Abstract]   [Full Text] [Related]  

  • 98. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety.
    Redmond DE; Huang YH
    Life Sci; 1979 Dec; 25(26):2149-62. PubMed ID: 120478
    [No Abstract]   [Full Text] [Related]  

  • 99. Current concepts. I. Anxiety: the locus coeruleus disconnection.
    Mason ST; Fibiger HC
    Life Sci; 1979 Dec; 25(26):2141-7. PubMed ID: 396433
    [No Abstract]   [Full Text] [Related]  

  • 100. Neurobiological mechanisms in human anxiety. Evidence supporting central noradrenergic hyperactivity.
    Charney DS; Redmond DE
    Neuropharmacology; 1983 Dec; 22(12B):1531-6. PubMed ID: 6142428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.